Header Logo

KHANH D VU

Concepts (55)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Venous Thromboembolism
2
2017
376
0.730
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2014
2903
0.340
 Why?
Hyperglycemia
1
2012
337
0.330
 Why?
Leukemia, Myeloid, Acute
3
2017
7265
0.280
 Why?
Insulin
1
2012
1483
0.270
 Why?
Incidence
2
2017
5824
0.130
 Why?
Vincristine
2
2012
1583
0.130
 Why?
Texas
2
2017
6449
0.120
 Why?
Platelet Count
1
2014
492
0.110
 Why?
Insulin, Long-Acting
1
2012
18
0.100
 Why?
Insulin Glargine
1
2012
20
0.100
 Why?
Young Adult
4
2017
22251
0.100
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2012
16689
0.100
 Why?
C-Peptide
1
2012
122
0.100
 Why?
Aged, 80 and over
4
2017
30998
0.100
 Why?
Thiazolidinediones
1
2012
147
0.100
 Why?
Adolescent
4
2017
32767
0.090
 Why?
Cancer Care Facilities
1
2014
907
0.090
 Why?
Burkitt Lymphoma
1
2012
350
0.080
 Why?
Risk Factors
2
2017
17888
0.080
 Why?
Metformin
1
2012
393
0.080
 Why?
Hypoglycemic Agents
1
2012
599
0.070
 Why?
Blood Glucose
1
2012
1269
0.070
 Why?
Dexamethasone
1
2012
1516
0.070
 Why?
Aged
6
2017
73333
0.070
 Why?
Prevalence
1
2014
3404
0.070
 Why?
Neoplasm Recurrence, Local
2
2017
10400
0.060
 Why?
Adult
5
2017
82040
0.060
 Why?
Middle Aged
6
2017
90352
0.060
 Why?
Doxorubicin
1
2012
3145
0.060
 Why?
Cohort Studies
1
2017
9470
0.060
 Why?
Cyclophosphamide
1
2012
3245
0.060
 Why?
Peripheral Nervous System Diseases
1
2007
401
0.050
 Why?
Male
6
2017
128315
0.050
 Why?
Antineoplastic Agents, Phytogenic
1
2007
894
0.050
 Why?
Female
6
2017
148940
0.050
 Why?
Time Factors
1
2014
13006
0.050
 Why?
Disease-Free Survival
1
2012
10265
0.040
 Why?
Follow-Up Studies
1
2014
15218
0.040
 Why?
Pain
1
2007
1694
0.040
 Why?
Prospective Studies
1
2012
13414
0.040
 Why?
Humans
6
2017
270740
0.030
 Why?
Prognosis
1
2012
22505
0.030
 Why?
Treatment Outcome
2
2012
33737
0.030
 Why?
Retrospective Studies
1
2014
39890
0.020
 Why?
Neoplasms
2
2007
15927
0.020
 Why?
Medical Records
1
2010
442
0.020
 Why?
Anthracyclines
1
2010
339
0.020
 Why?
Afferent Pathways
1
2007
66
0.020
 Why?
Cytarabine
1
2010
2014
0.010
 Why?
Remission Induction
1
2010
3656
0.010
 Why?
Pain Measurement
1
2007
1016
0.010
 Why?
Chronic Disease
1
2007
1824
0.010
 Why?
Comorbidity
1
2005
2394
0.010
 Why?
Survival Rate
1
2010
12541
0.010
 Why?
VU's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (55)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_